Immix Net Working Capital vs Short Long Term Debt Analysis

IMMX Stock

USD 1.68 0.14 7.69%

Immix Biopharma financial indicator trend analysis is infinitely more than just investigating Immix Biopharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immix Biopharma is a good investment. Please check the relationship between Immix Biopharma Net Working Capital and its Short Long Term Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.

Net Working Capital vs Short Long Term Debt

Net Working Capital vs Short Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immix Biopharma Net Working Capital account and Short Long Term Debt. At this time, the significance of the direction appears to have pay attention.

The correlation between Immix Biopharma's Net Working Capital and Short Long Term Debt is -0.97. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Short Long Term Debt in the same time period over historical financial statements of Immix Biopharma, assuming nothing else is changed. The correlation between historical values of Immix Biopharma's Net Working Capital and Short Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Immix Biopharma are associated (or correlated) with its Short Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt has no effect on the direction of Net Working Capital i.e., Immix Biopharma's Net Working Capital and Short Long Term Debt go up and down completely randomly.

Correlation Coefficient

-0.97

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Working Capital

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Most indicators from Immix Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immix Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.At this time, Immix Biopharma's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 28.8 M in 2024, whereas Tax Provision is likely to drop slightly above 12.5 K in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	1.4M	8.2M	16.1M	16.9M
Cost Of Revenue	2.5K	2.1K	5.5K	3.0K

Total Operating Expenses Cost Of Revenue

Immix Biopharma fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt
Total Assets		-0.97	0.63	-0.83	1.0	0.97	0.52	-0.98	-0.93	0.54	1.0	0.6	1.0	0.57	0.98	-0.97	0.92	0.99	-0.83	1.0	0.52	-0.97	1.0	0.98	1.0	-0.97
Short Long Term Debt Total	-0.97		-0.69	0.87	-0.97	-0.99	-0.56	0.99	0.96	-0.59	-0.97	-0.64	-0.97	-0.62	-0.95	1.0	-0.92	-0.97	0.86	-0.97	-0.56	1.0	-0.97	-0.95	-0.97	1.0
Other Current Liab	0.63	-0.69		-0.27	0.57	0.65	0.89	-0.69	-0.86	0.91	0.6	0.93	0.6	0.94	0.76	-0.71	0.72	0.7	-0.26	0.57	0.89	-0.69	0.63	0.73	0.57	-0.69
Total Current Liabilities	-0.83	0.87	-0.27		-0.88	-0.88	-0.15	0.85	0.7	-0.16	-0.85	-0.23	-0.85	-0.2	-0.71	0.85	-0.72	-0.77	1.0	-0.88	-0.15	0.87	-0.83	-0.73	-0.88	0.87
Total Stockholder Equity	1.0	-0.97	0.57	-0.88		0.98	0.46	-0.98	-0.9	0.48	1.0	0.54	1.0	0.51	0.95	-0.97	0.9	0.98	-0.88	1.0	0.46	-0.97	1.0	0.96	1.0	-0.97
Net Tangible Assets	0.97	-0.99	0.65	-0.88	0.98		0.56	-1.0	-0.94	0.58	0.98	0.64	0.98	0.61	0.94	-1.0	0.88	0.95	-0.89	0.98	0.56	-0.99	0.97	0.94	0.98	-0.99
Property Plant And Equipment Net	0.52	-0.56	0.89	-0.15	0.46	0.56		-0.6	-0.75	1.0	0.5	0.99	0.5	0.99	0.67	-0.6	0.51	0.57	-0.16	0.47	1.0	-0.56	0.52	0.62	0.45	-0.56
Net Debt	-0.98	0.99	-0.69	0.85	-0.98	-1.0	-0.6		0.96	-0.62	-0.98	-0.67	-0.98	-0.64	-0.96	1.0	-0.9	-0.97	0.86	-0.98	-0.6	0.99	-0.98	-0.96	-0.98	0.99
Retained Earnings	-0.93	0.96	-0.86	0.7	-0.9	-0.94	-0.75	0.96		-0.77	-0.92	-0.82	-0.92	-0.81	-0.96	0.97	-0.92	-0.95	0.7	-0.9	-0.75	0.96	-0.93	-0.95	-0.9	0.96
Accounts Payable	0.54	-0.59	0.91	-0.16	0.48	0.58	1.0	-0.62	-0.77		0.52	1.0	0.52	0.99	0.68	-0.62	0.54	0.59	-0.18	0.49	1.0	-0.59	0.54	0.64	0.47	-0.59
Cash	1.0	-0.97	0.6	-0.85	1.0	0.98	0.5	-0.98	-0.92	0.52		0.58	1.0	0.55	0.96	-0.97	0.9	0.98	-0.86	1.0	0.5	-0.97	1.0	0.97	1.0	-0.97
Non Current Assets Total	0.6	-0.64	0.93	-0.23	0.54	0.64	0.99	-0.67	-0.82	1.0	0.58		0.58	0.99	0.73	-0.68	0.6	0.65	-0.24	0.55	0.99	-0.64	0.6	0.69	0.53	-0.64
Cash And Short Term Investments	1.0	-0.97	0.6	-0.85	1.0	0.98	0.5	-0.98	-0.92	0.52	1.0	0.58		0.55	0.96	-0.97	0.9	0.98	-0.86	1.0	0.5	-0.97	1.0	0.97	1.0	-0.97
Net Receivables	0.57	-0.62	0.94	-0.2	0.51	0.61	0.99	-0.64	-0.81	0.99	0.55	0.99	0.55		0.72	-0.65	0.61	0.63	-0.2	0.52	0.99	-0.62	0.57	0.68	0.51	-0.62
Common Stock Shares Outstanding	0.98	-0.95	0.76	-0.71	0.95	0.94	0.67	-0.96	-0.96	0.68	0.96	0.73	0.96	0.72		-0.96	0.94	0.99	-0.71	0.95	0.67	-0.95	0.98	1.0	0.95	-0.95
Non Current Liabilities Total	-0.97	1.0	-0.71	0.85	-0.97	-1.0	-0.6	1.0	0.97	-0.62	-0.97	-0.68	-0.97	-0.65	-0.96		-0.92	-0.97	0.85	-0.97	-0.6	1.0	-0.97	-0.96	-0.97	1.0
Other Current Assets	0.92	-0.92	0.72	-0.72	0.9	0.88	0.51	-0.9	-0.92	0.54	0.9	0.6	0.9	0.61	0.94	-0.92		0.96	-0.69	0.89	0.51	-0.92	0.92	0.95	0.91	-0.92
Other Stockholder Equity	0.99	-0.97	0.7	-0.77	0.98	0.95	0.57	-0.97	-0.95	0.59	0.98	0.65	0.98	0.63	0.99	-0.97	0.96		-0.77	0.97	0.57	-0.97	0.99	1.0	0.98	-0.97
Total Liab	-0.83	0.86	-0.26	1.0	-0.88	-0.89	-0.16	0.86	0.7	-0.18	-0.86	-0.24	-0.86	-0.2	-0.71	0.85	-0.69	-0.77		-0.88	-0.16	0.86	-0.84	-0.72	-0.88	0.86
Net Invested Capital	1.0	-0.97	0.57	-0.88	1.0	0.98	0.47	-0.98	-0.9	0.49	1.0	0.55	1.0	0.52	0.95	-0.97	0.89	0.97	-0.88		0.47	-0.97	1.0	0.96	1.0	-0.97
Property Plant And Equipment Gross	0.52	-0.56	0.89	-0.15	0.46	0.56	1.0	-0.6	-0.75	1.0	0.5	0.99	0.5	0.99	0.67	-0.6	0.51	0.57	-0.16	0.47		-0.56	0.52	0.62	0.45	-0.56
Short Long Term Debt	-0.97	1.0	-0.69	0.87	-0.97	-0.99	-0.56	0.99	0.96	-0.59	-0.97	-0.64	-0.97	-0.62	-0.95	1.0	-0.92	-0.97	0.86	-0.97	-0.56		-0.97	-0.95	-0.97	1.0
Total Current Assets	1.0	-0.97	0.63	-0.83	1.0	0.97	0.52	-0.98	-0.93	0.54	1.0	0.6	1.0	0.57	0.98	-0.97	0.92	0.99	-0.84	1.0	0.52	-0.97		0.98	1.0	-0.97
Capital Stock	0.98	-0.95	0.73	-0.73	0.96	0.94	0.62	-0.96	-0.95	0.64	0.97	0.69	0.97	0.68	1.0	-0.96	0.95	1.0	-0.72	0.96	0.62	-0.95	0.98		0.96	-0.95
Net Working Capital	1.0	-0.97	0.57	-0.88	1.0	0.98	0.45	-0.98	-0.9	0.47	1.0	0.53	1.0	0.51	0.95	-0.97	0.91	0.98	-0.88	1.0	0.45	-0.97	1.0	0.96		-0.97
Short Term Debt	-0.97	1.0	-0.69	0.87	-0.97	-0.99	-0.56	0.99	0.96	-0.59	-0.97	-0.64	-0.97	-0.62	-0.95	1.0	-0.92	-0.97	0.86	-0.97	-0.56	1.0	-0.97	-0.95	-0.97

Click cells to compare fundamentals

Immix Biopharma Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immix Net Working Capital vs Short Long Term Debt Analysis

Net Working Capital vs Short Long Term Debt

Net Working Capital vs Short Long Term Debt Correlation Analysis

Correlation Coefficient

Net Working Capital

Short Long Term Debt

Immix Biopharma fundamental ratios Correlations

Immix Biopharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Immix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets

Non Current Liabilities Total	- 1.0	Net Tangible Assets
Net Debt	- 1.0	Net Tangible Assets
Short Term Debt	- 0.99	Net Tangible Assets
Short Long Term Debt	- 0.99	Net Tangible Assets
Net Tangible Assets	- 0.99	Short Long Term Debt Total
Net Working Capital	- 0.98	Net Debt